Kendall Capital Partners

Funding rounds backed by Kendall Capital Partners.

Export CSV
Funding disclosed in full
$43M
Median round
$21.5M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Rejuvenate Bio

Develops gene therapies for age-related and chronic diseases in animals and humans

$6MStrategicBiotechUnited States
5 participantsConnecticut InnovationsDigitalisKendall Capital PartnersMerck Animal HealthVCapital
Centivax

Develops vaccines and therapies for universal protection against diverse targets

$37MUndisclosedBiotechUnited States
4 participantsKendall Capital PartnersMeiji Seika PharmaSigmas GroupStructure Fund